LON/0QK8 (LON/0QK8)

London Stock Exchange: LON/0QK8 · USD

$23.8

-0.32 (-1.3%)· Recorded snapshot

Market cap	9.1B
Revenue (ttm)	8.6B
Net income (ttm)	-801.2M
EPS (ttm)	-$1.56
P/E (forward)	11.6x
Dividend	$0.03 (0.17%)
Volume	5,177
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.6B
Net income (ttm): -801.2M
EPS (ttm): -$1.56
P/E (forward): 11.6x
Market cap: 9.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-14 02:00 UTC

Forward P/E11.6

P25 13.5P50 17.2P75 26

Trailing P/En/a

P25 17P50 25.3P75 39.5

ROE-14.4

P25 -59.1P50 -2.4P75 11.9

ROIC6.8

P25 -44P50 2.7P75 10.1

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All LON/0QK8 indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	37,500
Employees Change	-22,000%
Employees Change Percent	-36.67
Enterprise value	$14.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Industry PE	59.02
Isin	US0718131099
Last refreshed	2026-09-14
Market cap	$9.1B
Price	$23.77
Price currency	USD
Rev Per Employee	230,531.71x
Sector	Healthcare
Sector PE	20.55
Sector PE Fwd	13.32
Sic	3841
Symbol	lon/0QK8
Website	https://www.baxter.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.81%
EV/EBIT	21.26x
EV/EBITDA	9.88x
EV/FCF	23.83x
EV/Sales	1.73x
FCF yield	6.75%
Forward P/E	11.62x
P/B ratio	1.95x
P/S ratio	1.05x
PE Ratio10 Y	35.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.12%
EBITDA Margin	16.43%
FCF margin	7.24%
Gross margin	34.1%
Gross Profit	$2.9B
Gross Profit Growth	-7.52%
Gross Profit Growth Q	-0.17%
Gross Profit Growth3 Y	-7.09%
Gross Profit Growth5 Y	-4.4%
Net Income	$-801.2M
Net Income Growth Q	38.46%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-4.21%
Profit Margin	-9.27%
Profit Per Employee	$-21,365
Profitable Quarters	$1
ROA	2.85
Roa5y	2.55
ROCE	5.75
ROE	-14.37
Roe5y	-9.06
ROIC	6.8
Roic5y	5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.99%
Cagr3y	-13.1%
Cagr5y	-20.21%
Div CAGR10	-22.16%
Div CAGR3	-67.45%
Div CAGR5	-47.98%
EPS Growth Q	36.78
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	243.88%
FCF Growth3 Y	-2.82%
FCF Growth5 Y	-9.65%
OCF Growth	72.42%
OCF Growth10 Y	-0.51%
OCF Growth3 Y	-5.42%
OCF Growth5 Y	-8.67%
Revenue Growth	5.36x
Revenue Growth Q	5.34x
Revenue Growth Qo Q	9.59x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.54x
Revenue Growth5 Y	-1.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.56
Assets	$14.9B
Cash	$1.6B
Current Assets	$5.2B
Current Liabilities	$2.7B
Debt	$7.3B
Debt EBITDA	$4.82
Debt Equity	$1.56
Debt FCF	$11.86
Equity	$4.7B
Interest Coverage	3.19
Liabilities	$10.3B
Long Term Assets	$9.7B
Long Term Liabilities	$7.6B
Net Cash	$-5.7B
Net Cash By Market Cap	$-62.27
Net Debt EBITDA	$3.99
Net Debt Equity	$1.22
Net Debt FCF	$9.22
Tangible Book Value	$-2.1B
Tangible Book Value Per Share	$-4.01
WACC	5.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.95
Inventory Turnover	3.26
Net Working Capital	$1.6B
Quick ratio	1.13
Working Capital	$2.6B
Working Capital Turnover	$2.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.68%
Dividend Growth	-94.12%
Dividend Growth Years	0%
Dividend per share	$0.03
Dividend Years	14
Dividend Yield	0.17%
Ex Div Date	2026-08-28
Last Dividend	$0.01
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.99%
200-day SMA	20.47
3Y total return	-34.38%
50-day SMA	24.92
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.66%
All Time High	89.6
All Time High Change	-73.47%
All Time High Date	2022-02-09
All Time Low	15.74
All Time Low Change	51.02%
All Time Low Date	2026-03-30
ATR	0.88
Beta	0.6
Ch YTD	23.3
High	24.73
High52	29.91
High52 Date	2026-07-30
High52ch	-20.52%
Low	23.72
Low52	15.74
Low52 Date	2026-03-30
Low52ch	51.02%
Ma50ch	-4.6%
Price vs 200-day SMA	16.1%
RSI	35.33
RSI Monthly	44.15
RSI Weekly	54.8
Sharpe ratio	0.12x
Sharpe Ratio3y	-0.37x
Sharpe Ratio5y	-0.59x
Sortino ratio	0.29
Sortino Ratio3y	-0.34
Sortino Ratio5y	-0.62
Total Return	-0.51%
Tr YTD	23.47
Tr1m	-14.41%
Tr1w	-8.68%
Tr3m	15.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	514,445,317%
Net Borrowing	10,350,438
Shares Insiders	0.41%
Shares Institutions	110.87%
Shares Qo Q	0.58%
Shares Yo Y	0.68%
Short Ratio	3.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$527.6M
Adjusted OCF	907,454,800
Average Volume	7,050.25x
Bv Per Share	9.05
CAPEX	$-379.9M
Ch1m	-14.44
Ch1w	-8.68
Ch1y	-2.18
Ch3m	15.67
Ch3y	-37.94
Ch5y	-70.68
Ch6m	35.36
Change	-1.33%
Change From Open	-1.78
Close	24.09
Days Gap	0.46
Depreciation Amortization	704,569,101
Dollar Volume	123,057.3
Earnings Date	2026-10-29
EBIT	$701.7M
EBITDA	$1.4B
EPS	$-1.56
F Score	5
FCF	$614.3M
FCF EV Yield	4.2x
Financing CF	-203,499,000
Fiscal Year End	December
Founded	1,931
Goodwill	3,612,302,862
Income Tax	$365.5M
Investing CF	-421,318,300
Is Primary Listing	0
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Ma150	20.84
Ma150ch	14.05%
Ma20	25.78
Ma20ch	-7.8%
Net CF	352,731,600
Next Earnings Date	2026-10-29
Open	24.2
P FCF Ratio	14.81
P FCF Ratio SBC	17.25
P OCF Ratio	9.15
P OCF Ratio SBC	10.03
Payment Date	2026-10-01
Position In Range	4.95
Ppne	2,346,592,158
Price Date	2026-09-11
Price EBITDA	$6.41
Relative Volume	0.75x
Revenue	8,644,939,000x
SBC By Revenue	1x
Share Based Comp	86,675,500
Tax By Revenue	4.23x
Tr6m	35.49%
Volume	5,177
Z Score	2.39

Deeper analysis on LON/0QK8

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0QK8 report

Is a complete LON/0QK8 research report available?

No complete published report is available for lon/0QK8 (LON/0QK8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0QK8 (LON/0QK8)

London Stock Exchange: LON/0QK8 · USD

$23.8

-0.32 (-1.3%)· Recorded snapshot

Market cap	9.1B
Revenue (ttm)	8.6B
Net income (ttm)	-801.2M
EPS (ttm)	-$1.56
P/E (forward)	11.6x
Dividend	$0.03 (0.17%)
Volume	5,177
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.6B
Net income (ttm): -801.2M
EPS (ttm): -$1.56
P/E (forward): 11.6x
Market cap: 9.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-14 02:00 UTC

Forward P/E11.6

P25 13.5P50 17.2P75 26

Trailing P/En/a

P25 17P50 25.3P75 39.5

ROE-14.4

P25 -59.1P50 -2.4P75 11.9

ROIC6.8

P25 -44P50 2.7P75 10.1

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All LON/0QK8 indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	37,500
Employees Change	-22,000%
Employees Change Percent	-36.67
Enterprise value	$14.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Industry PE	59.02
Isin	US0718131099
Last refreshed	2026-09-14
Market cap	$9.1B
Price	$23.77
Price currency	USD
Rev Per Employee	230,531.71x
Sector	Healthcare
Sector PE	20.55
Sector PE Fwd	13.32
Sic	3841
Symbol	lon/0QK8
Website	https://www.baxter.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.81%
EV/EBIT	21.26x
EV/EBITDA	9.88x
EV/FCF	23.83x
EV/Sales	1.73x
FCF yield	6.75%
Forward P/E	11.62x
P/B ratio	1.95x
P/S ratio	1.05x
PE Ratio10 Y	35.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.12%
EBITDA Margin	16.43%
FCF margin	7.24%
Gross margin	34.1%
Gross Profit	$2.9B
Gross Profit Growth	-7.52%
Gross Profit Growth Q	-0.17%
Gross Profit Growth3 Y	-7.09%
Gross Profit Growth5 Y	-4.4%
Net Income	$-801.2M
Net Income Growth Q	38.46%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-4.21%
Profit Margin	-9.27%
Profit Per Employee	$-21,365
Profitable Quarters	$1
ROA	2.85
Roa5y	2.55
ROCE	5.75
ROE	-14.37
Roe5y	-9.06
ROIC	6.8
Roic5y	5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.99%
Cagr3y	-13.1%
Cagr5y	-20.21%
Div CAGR10	-22.16%
Div CAGR3	-67.45%
Div CAGR5	-47.98%
EPS Growth Q	36.78
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	243.88%
FCF Growth3 Y	-2.82%
FCF Growth5 Y	-9.65%
OCF Growth	72.42%
OCF Growth10 Y	-0.51%
OCF Growth3 Y	-5.42%
OCF Growth5 Y	-8.67%
Revenue Growth	5.36x
Revenue Growth Q	5.34x
Revenue Growth Qo Q	9.59x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.54x
Revenue Growth5 Y	-1.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.56
Assets	$14.9B
Cash	$1.6B
Current Assets	$5.2B
Current Liabilities	$2.7B
Debt	$7.3B
Debt EBITDA	$4.82
Debt Equity	$1.56
Debt FCF	$11.86
Equity	$4.7B
Interest Coverage	3.19
Liabilities	$10.3B
Long Term Assets	$9.7B
Long Term Liabilities	$7.6B
Net Cash	$-5.7B
Net Cash By Market Cap	$-62.27
Net Debt EBITDA	$3.99
Net Debt Equity	$1.22
Net Debt FCF	$9.22
Tangible Book Value	$-2.1B
Tangible Book Value Per Share	$-4.01
WACC	5.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.95
Inventory Turnover	3.26
Net Working Capital	$1.6B
Quick ratio	1.13
Working Capital	$2.6B
Working Capital Turnover	$2.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.68%
Dividend Growth	-94.12%
Dividend Growth Years	0%
Dividend per share	$0.03
Dividend Years	14
Dividend Yield	0.17%
Ex Div Date	2026-08-28
Last Dividend	$0.01
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.99%
200-day SMA	20.47
3Y total return	-34.38%
50-day SMA	24.92
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.66%
All Time High	89.6
All Time High Change	-73.47%
All Time High Date	2022-02-09
All Time Low	15.74
All Time Low Change	51.02%
All Time Low Date	2026-03-30
ATR	0.88
Beta	0.6
Ch YTD	23.3
High	24.73
High52	29.91
High52 Date	2026-07-30
High52ch	-20.52%
Low	23.72
Low52	15.74
Low52 Date	2026-03-30
Low52ch	51.02%
Ma50ch	-4.6%
Price vs 200-day SMA	16.1%
RSI	35.33
RSI Monthly	44.15
RSI Weekly	54.8
Sharpe ratio	0.12x
Sharpe Ratio3y	-0.37x
Sharpe Ratio5y	-0.59x
Sortino ratio	0.29
Sortino Ratio3y	-0.34
Sortino Ratio5y	-0.62
Total Return	-0.51%
Tr YTD	23.47
Tr1m	-14.41%
Tr1w	-8.68%
Tr3m	15.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	514,445,317%
Net Borrowing	10,350,438
Shares Insiders	0.41%
Shares Institutions	110.87%
Shares Qo Q	0.58%
Shares Yo Y	0.68%
Short Ratio	3.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$527.6M
Adjusted OCF	907,454,800
Average Volume	7,050.25x
Bv Per Share	9.05
CAPEX	$-379.9M
Ch1m	-14.44
Ch1w	-8.68
Ch1y	-2.18
Ch3m	15.67
Ch3y	-37.94
Ch5y	-70.68
Ch6m	35.36
Change	-1.33%
Change From Open	-1.78
Close	24.09
Days Gap	0.46
Depreciation Amortization	704,569,101
Dollar Volume	123,057.3
Earnings Date	2026-10-29
EBIT	$701.7M
EBITDA	$1.4B
EPS	$-1.56
F Score	5
FCF	$614.3M
FCF EV Yield	4.2x
Financing CF	-203,499,000
Fiscal Year End	December
Founded	1,931
Goodwill	3,612,302,862
Income Tax	$365.5M
Investing CF	-421,318,300
Is Primary Listing	0
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Ma150	20.84
Ma150ch	14.05%
Ma20	25.78
Ma20ch	-7.8%
Net CF	352,731,600
Next Earnings Date	2026-10-29
Open	24.2
P FCF Ratio	14.81
P FCF Ratio SBC	17.25
P OCF Ratio	9.15
P OCF Ratio SBC	10.03
Payment Date	2026-10-01
Position In Range	4.95
Ppne	2,346,592,158
Price Date	2026-09-11
Price EBITDA	$6.41
Relative Volume	0.75x
Revenue	8,644,939,000x
SBC By Revenue	1x
Share Based Comp	86,675,500
Tax By Revenue	4.23x
Tr6m	35.49%
Volume	5,177
Z Score	2.39

Deeper analysis on LON/0QK8

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this LON/0QK8 report

Is a complete LON/0QK8 research report available?

No complete published report is available for lon/0QK8 (LON/0QK8) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0QK8 (LON/0QK8)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0QK8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0QK8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0QK8

Frequently asked questions

LON/0QK8 (LON/0QK8)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0QK8

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0QK8 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0QK8

Frequently asked questions